Leave Your Message
Looking to buy China Bromhexin Hcl 500ml in 2026? Well, it’s not just about comparing prices on some supplier website. The thing is, this product could be a ready-to-use oral solution, a medicine manufactured under contract, or even a bulk pharmaceutical ingredient. Each of these options comes with its own set of documentation, storage, and registration rules—so it's pretty important to get to know the product first before jumping in.
Dr. Helen Liu, a pharma quality expert with loads of experience in sourcing from China, likes to remind people, “Don’t buy the label; buy the proof.” Basically, she’s saying, don’t take things at face value. Make sure to ask every supplier for a valid GMP certificate, detailed product specs, a Certificate of Analysis, stability data, batch number, and their manufacturing license. You want to double-check that the 500ml volume, bromhexine hydrochloride strength, dosage form, and packaging all line up with what your market needs. A clear product photo can help, but don’t rely on that as proof alone.
If you’re serious, it’s smart to audit the supplier’s facility or hire an independent inspection company. Pay close attention to the production date, tamper-evident seals, markings on the carton, and the conditions during transport—like temperature controls. It’s also a good idea to request samples before committing to a big order. Test the lab results yourself and compare them with the supplier’s COA. Overlooking even small details can lead to delays at customs or might mess up your distribution plans—that’s just part of the game.
You might come across suppliers such as China Pharma Supply or Jiangsu Hengrui Medicine during your research. But just knowing their names isn’t enough to judge if they’re right for you. Always verify their current authorization status and export capabilities through official records. And don’t forget to review payment terms, recall procedures, insurance policies, and local regulations in your destination country. A lot of buyers tend to focus solely on getting the lowest quote, but that can sometimes lead to more costly rework later on. It’s really all about finding a balanced 2026 purchasing plan—one that considers price, proof of quality, compliance, and reliable communication instead of just going cheap.
Bromhexin Hcl 500ml generally refers to a 500 mL liquid preparation containing bromhexine hydrochloride. The bottle size alone does not define the product. Buyers should confirm the active concentration, dosage form, excipients, measuring device, and intended market. A clear product specification is essential.
In China procurement for 2026, request a current specification sheet, certificate of analysis, manufacturing authorization, and batch traceability records. Check whether the product is an oral solution or another liquid form. These details affect registration, labeling, transport, and final use. Inspect sample packaging carefully. The bottle should have a secure seal, readable lot number, expiry date, and consistent fill volume. Small details matter.
A practical buying scope may include samples, pilot quantities, or scheduled bulk orders. Ask about minimum order quantities, production lead time, payment terms, and export documentation. Confirm that the supplier can support your destination country’s pharmaceutical requirements. Independent testing may be sensible for concentration, microbial quality, and appearance. Do not rely only on a polished quotation.
I have seen procurement plans focus too heavily on price. That approach can overlook stability data or weak documentation. A spreadsheet can still hide important gaps. Recheck every claim against original records. Also, “Bromhexin Hcl 500ml” may appear as a search term, while the formal product name differs. That mismatch deserves careful review before contracting.
| Category | Data Dimension | Verified Product or Procurement Data | 2026 Buying Scope and Action |
|---|---|---|---|
| Product Definition | Active pharmaceutical ingredient | Bromhexine hydrochloride, commonly abbreviated as Bromhexine HCl; molecular formula C14H21Br2ClN2O2; relative molecular mass approximately 412.60 g/mol. | Confirm that the quotation is for the hydrochloride salt and not bromhexine free base or another mucolytic ingredient. |
| Pack Size | Nominal liquid volume | 500 mL means the nominal fill volume of the oral liquid in one retail or institutional container. It does not define the drug strength. | Request the net volume, allowable fill-volume tolerance, bottle count per carton, and outer-carton dimensions as separate specifications. |
| Strength Example | Concentration and total active content | If labeled 4 mg/5 mL, the concentration equals 0.8 mg/mL and a 500 mL bottle contains 400 mg of bromhexine HCl before any manufacturing overage. If labeled 8 mg/5 mL, the concentration equals 1.6 mg/mL and the bottle contains 800 mg. | Do not compare offers until the strength, dose volume, measuring device, and total active content are identical. |
| Dosage Form | Oral liquid presentation | A 500 mL product may be an oral solution, syrup, or suspension. These terms describe different formulation characteristics and must not be treated as interchangeable. | Specify dosage form, appearance, pH range, viscosity where applicable, sedimentation or redispersibility requirements, and whether shaking is required. |
| Excipient Control | Inactive ingredients and allergen suitability | The excipient system can include sweeteners, flavoring agents, preservatives, solvents, buffers, viscosity modifiers, and purified water. The actual composition is product-specific. | Obtain the complete quantitative or qualitative excipient list and screen for sugar, alcohol, sodium, sulfites, allergens, and other market-specific restrictions. |
| Container System | Primary packaging | Common liquid-drug packaging uses a glass or pharmaceutical-grade plastic bottle with a closure. The actual material, light protection, seal, and child-resistance depend on the approved product specification. | Require bottle material, closure type, tamper-evidence, compatibility data, extractables and leachables assessment where applicable, and transport-leak testing. |
| Measuring Device | Dose-measurement accessory | A dosing cup, oral syringe, or dropper may be supplied depending on the product and target market. The device should have readable volume graduations. | State the accessory type, graduation interval, material, unit system, and whether one device is included per bottle or per carton. |
| Quality Standard | Release and stability testing | A finished oral liquid specification commonly covers identification, assay, related substances, pH where applicable, microbial quality, appearance, fill volume, and preservative content where applicable. | Request the finished-product specification, certificate of analysis, validated analytical methods or method references, stability summary, and sample batch records. |
| China Regulatory Check | Domestic registration and manufacturing authorization | For the Chinese domestic market, the product and manufacturing site should be checked against applicable National Medical Products Administration requirements. Registration status, dosage form, strength, and approved packaging must match the offered product. | Verify the applicable registration certificate or filing information, manufacturing license scope, approved package insert, and current GMP compliance evidence before purchase. |
| Export Compliance | Destination-market requirements | A product legally marketed in China is not automatically authorized for sale in another country. Import requirements may include product registration, legalized documents, labeling review, language requirements, and an importer or marketing authorization holder. | Define the destination country before requesting a final quotation and identify all documents required by the destination regulator and customs authority. |
| Label Information | Mandatory product particulars | The label and package insert should clearly state the active ingredient, strength, dosage form, net volume, batch or lot number, manufacturing date, expiry date, storage conditions, administration instructions, and warnings required by the applicable market. | Approve artwork only after regulatory review; ensure the 500 mL volume and mg-per-5-mL strength are displayed clearly and consistently. |
| Shelf Life | Remaining shelf life at shipment | Shelf life is established by the approved stability data and is product-specific; it should not be assumed from the 500 mL pack size. | Include a minimum remaining-shelf-life requirement in the purchase contract and require batch-specific expiry information before dispatch. |
| Storage and Transport | Temperature, light, and handling | Storage conditions must follow the approved label and stability data. Heat, freezing, excessive light, and rough handling may affect liquid products or their packaging. | Request the labeled storage range, transport excursion limits, pallet configuration, leak-protection measures, and temperature-monitoring requirements where needed. |
| Commercial Unit | Packing and shipment configuration | The commercial unit should distinguish one 500 mL bottle from the inner carton, master carton, pallet, and total shipment quantity. Exact quantities vary by bottle and carton dimensions. | Request a packing list showing bottles per carton, cartons per pallet, gross and net weight, cubic volume, pallet dimensions, and total shipment quantity. |
| Quality Documents | Pre-order documentation package | A practical document set may include a product specification, batch certificate of analysis, safety data information where applicable, manufacturing authorization evidence, packaging specification, stability data, and certificate of origin. | Make document submission, sample approval, batch release, and change-notification obligations conditions of purchase. |
| 2026 Cost Scope | Total landed cost | The final cost is not determined by the 500 mL volume alone. It can include product price, packaging, testing, translation or artwork, registration support, freight, insurance, customs duties, taxes, inspection, and local distribution. | Compare quotations on the same Incoterm, currency, minimum order quantity, specification, documentation package, and destination—not on unit price alone. |
| Supplier Qualification | Audit and communication controls | A qualified pharmaceutical source should be able to provide consistent batch documentation, traceability, quality agreements, change-control procedures, complaint handling, and recall support. | Use a written quality agreement, approve a pre-production sample, conduct risk-based due diligence, and confirm that no unapproved formulation or packaging substitution is permitted. |
Lincomycin–spectinomycin injection and toltrazuril solution serve different roles in structured animal-care programs. The injectable combination is generally considered only when bacterial disease is suspected or confirmed and a veterinarian determines that treatment is appropriate. Before use, check the animal species, body weight, product concentration, injection route, contraindications, storage conditions, and withdrawal requirements on the approved label. Accurate dosing, sterile handling, and completion of the prescribed course help reduce treatment failure and unnecessary antimicrobial exposure.
Toltrazuril solution is an anticoccidial treatment used to control coccidiosis in susceptible young animals, particularly when clinical signs, fecal testing, or farm history indicate risk. It should be administered with calibrated equipment and supported by hygiene measures, dry bedding, clean water, and reduced stocking pressure. Treatment records should include date, animal group, dose, response, and withdrawal period. The need for careful selection is reinforced by international evidence: FAO has cited estimates that animal diseases can account for losses of up to 20% of production, while the WHO’s 2019 global assessment attributed approximately 1.27 million human deaths directly to bacterial antimicrobial resistance. These findings support veterinary diagnosis, responsible antimicrobial use, and routine monitoring rather than preventive medication without a clear indication.
It usually means a liquid preparation containing Bromhexine HCl in a 500 mL bottle. The bottle size alone proves little. Confirm concentration, dosage form, excipients, measuring device, and intended market.
Request the current specification sheet, certificate of analysis, manufacturing authorization, and batch traceability records. Also ask for manufacturing date, shelf life, storage conditions, and export documents. Do not guess.
Check whether it is an oral solution or another liquid preparation. The dosage form affects labeling, registration, transport, and final use. A product photograph may not reveal enough.
Verify assay, identity, related substances, degradation products, and microbial limits. Review residual solvents, elemental impurities, and preservative content when applicable. Independent testing can compare the supplier’s certificate with measured results.
Use the applicable pharmacopoeial method for assay and identity testing. Infrared spectroscopy, supported by chromatographic testing, provides stronger confirmation. One method may not be enough.
Check the secure seal, tamper evidence, readable lot number, expiry date, and consistent fill volume. Inspect transport temperature and packaging photographs after delivery. Small details matter.
Compare stability data, documentation quality, testing results, lead time, and minimum order quantity. A low quotation may hide missing chromatograms or incomplete raw data. Price is not the whole decision.
Confirm the product specification, applicable pharmacopoeia, payment terms, delivery schedule, and destination-market requirements. Request a representative sample from the same batch. Keep every document version for traceability.
They may treat “500 mL” as a complete product description. That assumption can overlook concentration, impurities, stability, or documentation gaps. I would recheck every claim against original records.
Buying China Bromhexin Hcl 500ml in 2026 requires a structured quality, compliance, and cost evaluation rather than a simple price comparison. First, define the exact product, dosage form, intended market, and packaging requirements. Verify the assay, identity, impurities, and other specifications against the applicable pharmacopoeia. Potential suppliers should be screened for valid NMPA registration, China GMP compliance, appropriate manufacturing capacity, and transparent quality systems. Compare MOQ, 500 mL pricing, payment terms, Incoterms, freight, insurance, duties, and other factors that determine the total landed cost.
Before purchase, review the COA, batch records, traceability procedures, and key manufacturing documentation. Stability data should be assessed carefully, including ICH Q1A(R2)-aligned evidence at 40°C/75% RH for six months where applicable. Import documents, labeling, storage conditions, transport controls, and final quality release procedures must also be confirmed in advance. A complete due-diligence process helps buyers reduce supply risks and establish a reliable, documented procurement pathway for China Bromhexin Hcl 500ml.
Send Email
